Basics Aquestive Therapeutics, Inc. IPO Date: July 23, 2018 Sector: Healthcare Industry: Drug Manufacturers - Specialty and Generic Market Cap: $655.68M Activated in VL: True Average Daily Range Avg Daily Range: $0.16 | 3.73% Avg Daily Range (30 D): $0.13 | 3.10% Avg Daily Range (90 D): $0.11 | 3.28% Institutional Daily Volume Avg Daily Volume: .73M Avg Daily Volume (30 D): 1.73M Avg Daily Volume (90 D): 1.52M Trade Size Avg Trade Size (Sh.): 177 Avg Trade Size (Sh.) (30 D): 161 Avg Trade Size (Sh.) (90 D): 165 Institutional Trades Total Inst.Trades: 137 Avg Inst. Trade: $1.86M Avg Inst. Trade (30 D): $1.01M Avg Inst. Trade (90 D): $1.04M Avg Inst. Trade Volume: .48M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.1M Avg Closing Trade (30 D): $.71M Avg Closing Trade (90 D): $.98M Avg Closing Volume: 497.84K     News Sep 4, 2025 @ 11:00 AM Aquestive Therapeutics Announces that FDA Will Not... Source: Aquestive Therapeutics Aug 14, 2025 @ 10:00 AM Aquestive Therapeutics Announces $75M Strategic Fu... Source: Aquestive Therapeutics Jul 22, 2025 @ 11:00 AM Aquestive Therapeutics Names Sherry Korczynski as ... Source: Aquestive Therapeutics Apr 9, 2025 @ 11:00 AM Aquestive Therapeutics to Participate in Piper San... Source: N/A Feb 12, 2025 @ 12:00 PM Aquestive Therapeutics to Present New Findings on ... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.69 $-.14 $-.24 Diluted EPS $-.69 $-.14 $-.24 Revenue $ 44.13M $ 10M $ 8.72M Gross Profit $ 26.96M $ 5.44M $ 5.07M Net Income / Loss $ -65.04M $ -13.55M $ -22.93M Operating Income / Loss $ -52.6M $ -11.37M $ -19.37M Cost of Revenue $ 17.17M $ 4.56M $ 3.65M Net Cash Flow $ -29.33M $ -8.12M $ -2.89M PE Ratio